A radical, potentially game-changing technology that threatens to destroy the trillion-dollar, “green energy” grift of the elites. And yet, while it threatens their wealth and power, it could be transformational for both the U.S. economy and your wealth.

One company holds a near-total monopoly on it.

David Lewis Biography and Net Worth

Director of STERIS

David B. Lewis is Independent Director of the company. He is director since July 2010 and of counsel with Lewis & Munday since August 1, 2014, a Detroit based law firm with offices in Washington, D.C. and New York, NY. He was a partner in the firm from its creation in 1972 to August 2014, specializing in the issuance of municipal bonds for states and local governments. He served as its President and Chief Executive Officer from 1972 to 1982 and its Chairman and Chief Executive Officer from 1982 to January 2011. He is a director of H&R Block, Inc. Previously, Mr. Lewis served on the Boards of Conrail, Inc., LG&E Energy Corp., M.A. Hanna, TRW, Inc., The Kroger Company, and Comerica, Inc. Mr. Lewis is a member of the committee which governs the UAW Retiree Medical Benefits Trust, a voluntary employee benefits trust which delivers medical/health benefits to retired employees of Fiat Chrysler, Ford, and General Motors and also chairs the audit subcommittee of the Trust.

What is David B. Lewis' net worth?: The estimated net worth of David B. Lewis is at least $1.91 million as of December 1st, 2020. Mr. Lewis owns 8,244 shares of STERIS stock worth more than $1,907,085 as of May 11th. This net worth approximation does not reflect any other investments that Mr. Lewis may own. Learn More about David B. Lewis' net worth.
How do I contact David B. Lewis?: The corporate mailing address for Mr. Lewis and other STERIS executives is 70 Sir John Rogerson`s Quay, Dublin L2, D02 R296. STERIS can also be reached via phone at (440) 354-2600 and via email at [email protected]. Learn More on David B. Lewis' contact information.
Has David B. Lewis been buying or selling shares of STERIS?: David B. Lewis has not been actively trading shares of STERIS during the last quarter. Most recently, David B. Lewis sold 1,560 shares of the business's stock in a transaction on Tuesday, December 1st. The shares were sold at an average price of $193.79, for a transaction totalling $302,312.40. Following the completion of the sale, the director now directly owns 8,244 shares of the company's stock, valued at $1,597,604.76. Learn More on David B. Lewis' trading history.
Who are STERIS's active insiders?: STERIS's insider roster includes Richard Breeden (Director), Karen Burton (CAO), Daniel Carestio (SVP), Cynthia Feldmann (Director), Jacqueline Kosecoff (Director), David Lewis (Director), Julia Madsen (VP), Cary Majors (SVP), Walter Rosenbrough, Jr. (CEO), Mohsen Sohi (Director), Renato Tamaro (VP), Michael Tokich (CFO), and John Zangerle (VP). Learn More on STERIS's active insiders.
Are insiders buying or selling shares of STERIS?: In the last twelve months, insiders at the medical equipment provider sold shares 1 times. They sold a total of 2,069 shares worth more than $439,207.32. The most recent insider tranaction occured on May, 15th when Director Mohsen Sohi sold 2,069 shares worth more than $439,207.32. Insiders at STERIS own 1.0% of the company. Learn More about insider trades at STERIS.
Information on this page was last updated on 5/15/2023.

David B. Lewis Insider Trading History at STERIS

Transaction Date	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction	Details
12/1/2020	Sell	1,560	$193.79	$302,312.40	8,244

David B. Lewis Buying and Selling Activity at STERIS

STERIS Company Overview

STERIS plc provides infection prevention products and services worldwide. It operates through four segments: Healthcare, Applied Sterilization Technologies, Life Sciences, and Dental. The Healthcare segment offers cleaning chemistries and sterility assurance products; automated endoscope reprocessing system and tracking products; endoscopy accessories, washers, sterilizers, and other pieces of capital equipment for the operation of a sterile processing department; and equipment used directly in the operating room, including surgical tables, lights, and connectivity solutions, as well as equipment management services. It also provides capital equipment installation, maintenance, upgradation, repair, and troubleshooting services; preventive maintenance programs and repair services; instrument and endoscope repair and maintenance services; and custom process improvement consulting and outsourced instrument sterile processing services. The Applied Sterilization Technologies segment provides contract sterilization and testing services for medical device and pharmaceutical manufacturers through a network of approximately 50 contract sterilization and laboratory facilities. The Life Sciences segment designs, manufactures and sells consumable products, such as formulated cleaning chemistries, barrier, sterility assurance products, steam and vaporized hydrogen peroxide sterilizers, and washer disinfectors. This segment also offers equipment installation, maintenance, upgradation, repair, and troubleshooting services; and preventive maintenance programs and repair services. The Dental segment provides hand and electric-powered dental instruments, infection control products, conscious sedation, personal protective equipment, and water quality products for dental suite. The company serves its products and services to hospitals, other healthcare providers, and pharmaceutical manufacturers. The company was founded in 1985 and is based in Dublin, Ireland.

Today's Range

Now: $231.33

$223.68

$231.74

50 Day Range

MA: $216.99

$198.94

$233.84

2 Week Range

Now: $231.33

$195.47

$254.00

Volume

867,834 shs

Average Volume

606,704 shs

Market Capitalization

$22.86 billion

P/E Ratio

60.56

Dividend Yield

0.92%

Beta

0.81

Elon to Transform U.S. Economy?

From Porter & Company | Ad